Indacaterol and its Impurities

Indacaterol Used for treatment of chronic obstructive pulmonary disease. It is marketed in Europe as Onbrez and in America as Arcapta Neohaler. Reference standards of Indacaterol API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 12 results for Indacaterol Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 09 1450000

Indacaterol

Indacaterol


  • Catalogue No.:PA 09 1450000

  • CAS :

    312753-06-3

  • Molecular Formula : C24H28N2O3

  • Molecular Weight : 392.5

Drug Reference Standards & Impurity Synthesis in India
PA 09 1451000

(R)-8-(Benzyloxy)-5-(2-bromo-1-((tert-butyldimethylsilyl)oxy)ethyl)quinolin-2(1H)-one

(R)-8-(Benzyloxy)-5-(2-bromo-1-((tert-butyldimethylsilyl)oxy)ethyl)quinolin-2(1H)-one


  • Catalogue No.:PA 09 1451000

  • CAS :

    530084-74-3

  • Molecular Formula : C24H30BrNO3Si

  • Molecular Weight : 488.5

Drug Reference Standards & Impurity Synthesis in India
PA 09 1451001

(R)-8-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one

(R)-8-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one


  • Catalogue No.:PA 09 1451001

  • CAS :

    530084-79-8

  • Molecular Formula : C18H16BrNO3

  • Molecular Weight : 374.23

Drug Reference Standards & Impurity Synthesis in India
PA 09 1451002

(R)-5-(2-((5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-ethoxyethyl)-8-hydroxyquinolin-2(1H)-one

(R)-5-(2-((5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-ethoxyethyl)-8-hydroxyquinolin-2(1H)-one


  • Catalogue No.:PA 09 1451002

  • CAS :

    NA

  • Molecular Formula : C26H32N2O3

  • Molecular Weight : 420.55

Drug Reference Standards & Impurity Synthesis in India
PA 09 1451003

Benzyl Indacaterol Hemitartrate Salt

Benzyl Indacaterol Hemitartrate Salt


  • Catalogue No.:PA 09 1451003

  • CAS :

    1629188-88-0

  • Molecular Formula : C31H34N2O3 + 1/2(C4H6O6)

  • Molecular Weight : 482.62 + 1/2(150.09)

Drug Reference Standards & Impurity Synthesis in India
PA 09 1451004

(S)-Indacaterol Acetate

(S)-Indacaterol Acetate


  • Catalogue No.:PA 09 1451004

  • CAS :

    2219344-56-4

  • Molecular Formula : C26H32N2O5

  • Molecular Weight : 452.55

Drug Reference Standards & Impurity Synthesis in India
PA 09 1451005

Benzyl Indacaterol S-Isomer

Benzyl Indacaterol S-Isomer


  • Catalogue No.:PA 09 1451005

  • CAS :

    312759-81-2

  • Molecular Formula : C31H34N2O3

  • Molecular Weight : 482.62

Drug Reference Standards & Impurity Synthesis in India
PA 09 1451006

Indacaterol Racemate

Indacaterol Racemate


  • Catalogue No.:PA 09 1451006

  • CAS :

    312753-33-6

  • Molecular Formula : C24H28N2O3

  • Molecular Weight : 392.5

Drug Reference Standards & Impurity Synthesis in India
PA STI 089941

Indacaterol-D3

Indacaterol-D3


  • Catalogue No.:PA STI 089941

  • CAS :

    2699828-16-3

  • Molecular Formula : C24H25D3N2O3

  • Molecular Weight : 395.52

Drug Reference Standards & Impurity Synthesis in India
PA 09 1451008

(R)-5-(2-(Benzyl(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one

(R)-5-(2-(Benzyl(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one


  • Catalogue No.:PA 09 1451008

  • CAS :

    1534342-47-6

  • Molecular Formula : C31H34N2O3

  • Molecular Weight : 482.62

Drug Reference Standards & Impurity Synthesis in India
PA 09 1451007

(R)-5-(2-(Benzyl(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-8-(benzyloxy)quinolin-2(1H)-one

(R)-5-(2-(Benzyl(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-8-(benzyloxy)quinolin-2(1H)-one


  • Catalogue No.:PA 09 1451007

  • CAS :

    1384189-12-1

  • Molecular Formula : C38H40N2O3

  • Molecular Weight : 572.75

Drug Reference Standards & Impurity Synthesis in India
PA 09 1451009

Benzyl Indacaterol S-Isomer Hemitartrate Salt

Benzyl Indacaterol S-Isomer Hemitartrate Salt


  • Catalogue No.:PA 09 1451009

  • CAS :

    NA

  • Molecular Formula : C31H34N2O3 + 1/2(C4H6O6)

  • Molecular Weight : 482.62 + 1/2(150.09)

pharmaffiliates